Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson's disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson's disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson's disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Status
Status :
Completed
Type of study
Phase IV
Min. Age
45
Years old
Max. Age
80
Years old
Gender
All
Therapeutic area :
Mental Health
Disease :
Parkinson disease
Study medication :
Debrumyl
Phase :
Phase IV
Start Date :
August 07, 2008
End date :
July 02, 2010
Study ID :
DC0158 AM 401 1B
EudraCT/CTIS number :
2007-002195-34
Send by email